131MO Tislelizumab (TIS) Plus Chemotherapy (chemo) Vs Placebo (PBO) Plus Chemo As First-Line (1L) Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (GC/GEJC): Patient Reported Outcomes (PRO) in the Asian Subgroup of the RATIONALE-305 Study

K. Kato, R-H. Xu, D-Y. Oh,Y. Bai,J. Shi, K-W. Lee, H. Hirano, H. Xu,T. Sheng, G. Barnes

Annals of Oncology（2024）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined